Top Section/Ad
Top Section/Ad
Most recent
Calendar quirk could keep issuance going in December
◆ Praemia refis at a tighter coupon ◆ Schneider lands tight at the short end ◆ Minimal concessions needed
French biotech seeks to accelerate cancer vaccine program
More articles/Ad
More articles/Ad
More articles
-
J&J’s rare 30 year tranche grows to €1bn
-
Corporate borrowers shrugged off fears over inflation and concerns over tariffs to print tight trades and pay for acquisitions
-
-
Fairfax sells Eurobank block and new flotation appears in Oman
-
Decision follows successful Phase 2 trial on intensive care patients
-
JP Morgan will take early lead in league table